Status:

COMPLETED

NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects

Lead Sponsor:

National University Hospital, Singapore

Conditions:

Cognitive Impairment

Eligibility:

All Genders

55-85 years

Phase:

PHASE2

Brief Summary

Patients who have suffered from stroke may develop problems with thinking. Moreover, such patients have a high risk of becoming demented, more dependent or dying. Therefore, further studies are urgent...

Detailed Description

A substantial proportion of patients after non-disabling stroke are cognitively impaired compared to aged and education matched community dwelling controls. Moreover, post-stroke patients who have vas...

Eligibility Criteria

Inclusion

  • Male and female patients
  • Aged 55 to 85, living with a caregiver,
  • Modified Rankin score \<=3.
  • Diagnosis of CIND due to cerebrovascular disease.
  • Cognitive impairment documented by neuropsychological evaluation within 12 months of index stroke/TIA. Not demented by DSM-IV criteria
  • Written informed consent by subject

Exclusion

  • Advanced, severe, and unstable disease of any type that may interfere with the efficacy evaluations or put the subject at special risk.
  • DSM IV current diagnosis of dementia or major depression (patients may be included if currently being treated on an antidepressant and stabilized after 3 months).
  • A disability that may prevent the subject from completing all study requirements (e.g. blindness, deafness, severe language difficulty).
  • Ingestion of any of the following : an investigational drug in the past four weeks, a drug or treatment known to cause major organ system toxicity during the past four weeks, acetylcholinesterase inhibitors or memantine in the past 3 months

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2018

Estimated Enrollment :

103 Patients enrolled

Trial Details

Trial ID

NCT01847924

Start Date

March 1 2013

End Date

April 1 2018

Last Update

July 27 2018

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

University of Santo Tomas Hospital

Manila, National Capital Region, Philippines, 1015

2

National University Hospital

Singapore, Singapore, 119074

3

Singapore General Hospital

Singapore, Singapore, 169608

4

National Neuroscience Institute

Singapore, Singapore, 308433